Ischemic stroke. Cerebral infarction
Conditions
Interventions
Intervention 1: Intervention group: A daily curcumin-piperine capsule(500 mg curcumin + 5 mg piperine) will receive after meal for 12 weeks. Intervention 2: Control group: A daily placebo capsule(505
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: The person has had a stroke only once At least 3-6 months have passed since the stroke (subacute and chronic phase) NIHSS =5-24 diagnosis of stroke by CT-scan and MRI Age=20-65 years old BMI=18/5-35 Tendency to participate in the study
Exclusion criteria
Exclusion criteria: Taking anticoagulants such as aspirin, heparin, warfarin, etc. Taking antioxidant and multivitamin supplements and omega-3 supplements Having malignant diseases and cancers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HS-CRP. Timepoint: The beginning and the end of the study. Method of measurement: ELISA kit.;TAC. Timepoint: The beginning and the end of the study. Method of measurement: Laboratory method.;Fibrinogen plasma level. Timepoint: The beginning and the end of the study. Method of measurement: ELISA kit.;Lipid profile. Timepoint: The beginning and the end of the study. Method of measurement: Enzymatic method.;Systolic and diastolic blood pressure. Timepoint: The beginning and the end of the study. Method of measurement: Mercury Barometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The beginning and the end of the study. Method of measurement: Digital scale.;Waist Circumference (WC). Timepoint: The beginning and the end of the study. Method of measurement: Inelastic meters.;Body mass index (BMI). Timepoint: The beginning and the end of the study. Method of measurement: Dividing the weight into kilograms by squared height by meter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKosar Boshagh
Esfahan University of Medical Sciences
Outcome results
None listed